BackPanbela Therapeutics Overview

Panbela Therapeutics Goodwill

Track Panbela Therapeutics's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

Panbela Therapeutics Goodwill History

Loading

Panbela Therapeutics vs. peers: Goodwill Comparison

Loading

Panbela Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Panbela Therapeutics (PBLA) FAQ

As of the most recent data (September 2024), PBLA shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBLA's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Panbela Therapeutics is outperforming or lagging.

Tracking PBLA's goodwill over time shows whether Panbela Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Panbela Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Panbela Therapeutics's goodwill is $0; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.